A review on the biological roles of LncRNA PTCSC3 in cancerous and non-cancerous disorders.
Majid GhasemianJafar PoodinehPublished in: Cancer cell international (2023)
Long non-coding RNA papillary thyroid carcinoma susceptibility candidate 3 (LncRNA PTCSC3) is located on human chromosome 14q13.3. PTCSC3 functions as a tumor suppressor lncRNA to regulate essential cellular processes such as apoptosis, cell proliferation, migration, invasion, angiogenesis, and epithelial-to-mesenchymal transition. PTCSC3 is also involved in the regulation of the Wnt/β-catenin signaling pathway, aerobic glycolysis, and p53 pathways. Downregulation of PTCSC3 has been associated with an increased risk of many tumors such as thyroid, gastric, laryngeal, breast, cervical, oral, lung, and glioma cancers. In addition, dysregulation of PTCSC3 has been reported in non-cancerous disorders notably osteoporosis and periodontitis. However, a number of single nucleotide polymorphisms at PTCSC3 have been linked to a higher risk of human diseases. This literature review summarizes the diagnostic, prognostic, and the clinical value of abnormal expression of PTCSC3 in cancerous and non-cancerous disorders and comprehensively analyzes potential molecular regulatory mechanism related to PTCSC3, which is expected to provide clear guidance for future PTCSC3 research.
Keyphrases
- long non coding rna
- poor prognosis
- cell proliferation
- endothelial cells
- oxidative stress
- stem cells
- transcription factor
- cell death
- long noncoding rna
- signaling pathway
- lymph node metastasis
- endoplasmic reticulum stress
- induced pluripotent stem cells
- postmenopausal women
- risk assessment
- current status
- climate change
- vascular endothelial growth factor